Andreas Koerner

Title: Innovations by Andreas Koerner

Introduction

Andreas Koerner is a notable inventor based in Springe, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of enzyme compositions and oral dosage forms. With a total of 2 patents, his work has had a meaningful impact on medicinal products.

Latest Patents

Koerner's latest patents include a "Delayed release pancreatin composition," which describes an enteric-coated oral dosage form. This composition is designed to be substantially free of monomeric phthalic acid esters and synthetic oils. The patent also outlines methods for making and using this enteric-coated oral dosage form. Another significant patent is the "Method of analyzing enzyme compositions with lipolytic, proteolytic, and amylolytic activity." This method focuses on analyzing the identity, protein, and peptide patterns of enzyme mixtures, particularly those used in manufacturing medicinal products.

Career Highlights

Throughout his career, Koerner has worked with prominent companies such as Solvay Pharmaceuticals GmbH and Abbott Products GmbH. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Koerner has collaborated with notable colleagues, including Andreas Potthoff and Bernd Thumbeck. These partnerships have likely enhanced his research and development efforts in the pharmaceutical industry.

Conclusion

Andreas Koerner's contributions to pharmaceutical innovations, particularly in enzyme compositions and oral dosage forms, highlight his role as a significant inventor in the field. His patents and collaborations reflect his commitment to advancing medicinal products.